The critical role of VEGFA in tumor angiogenesis was further validated by its association with poorer prognosis in NSCLC patients, as revealed by Kaplan–Meier survival analysis involving 2166 lung cancer patients (kmplot.com). This evidence concerns the gene VEGFA and non-small cell lung carcinoma.